Skip to main content
. 2023 Aug 2;11(8):1988. doi: 10.3390/microorganisms11081988

Figure 4.

Figure 4

SWOT analysis of particulate systems for the formulation of TB vaccines or treatments. HMDR: hypervirulent multi-drug resistance.